Oxford VR
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
Oxford VR was a University of Oxford spinout founded in 2016 from the psychiatry research of Professor Daniel Freeman, backed by Oxford Science Enterprises. It built evidence-based immersive VR treatments for serious mental illness, including gameChange - an automated cognitive-behavioural VR therapy for psychosis granted FDA Breakthrough Device designation and rolled out in the NHS.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Company founded
Oxford VR spins out of Oxford University's Department of Psychiatry to bring VR therapy to mental healthcare.
- Acquisition
Oxford VR is acquired by Rey, a US mental health company.
- Acquisition
In December 2022, OxfordVR merges with US company BehaVR under the BehaVR brand, supported by a $13 million Series B led by Optum Ventures and Oxford Science Enterprises.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.